findmyKOL

Alan Schatzberg, MD

Enriched profile

Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences · Stanford University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Stanford, CA · West · United StatesSpecialtyPsychiatryFocusDepression (MDD)
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1994–2026

Alan Schatzberg is Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. OpenAlex indexes 636 publications with 60,489 citations (h-index 109); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Psychiatry profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Alan Schatzberg, MD, is Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences. The public record shows 636 publications with 60,489 citations (h-index 109), centered on Depression (MDD). It also documents an investigator role on 7 registered clinical trials, industry payments reported by 7 companies, 7 NIH-funded awards (1994–2026).

  • Most recent indexed publication: 2026 · The American journal of psychiatry
  • Top research focus: Depression (MDD)
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Depression (MDD)5 trialsPsychotic Disorders2 trialsTic Disorders2 trialsMajor Depressive Disorder2 trialsStress Disorders, Post-Traumatic1 trial

Research focus

OpenAlex concept fingerprint
Depression (MDD)

Drugs & molecules

across trials, industry payments and publications
Zurzuvaegeneric · ZuranoloneClinical trials—Industry payments7Publications—Zulressogeneric · BrexanoloneClinical trials—Industry payments5Publications—DextroamphetamineClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Sage Therapeutics, Inc.Clinical trials—Industry payments51Janssen Scientific Affairs, LLCClinical trials—Industry payments11Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments9Boehringer Ingelheim International GmbHClinical trials—Industry payments7Sage Therapeutics, LLCClinical trials—Industry payments7Stanford UniversityClinical trials6Industry payments—Tris Pharma IncClinical trials—Industry payments3Grifols, S.A.Clinical trials—Industry payments2US Department of Veterans AffairsClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
636publications

Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.

60,489citations

Total citations across indexed works.

109h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
7companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
7NIH grants · 1994–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    100%
    Atypical Antipsychotic26.2%
    Olanzapine56%Lurasidone Hcl44%
    Part D<11 patients
    Aminoketone22.3%
    Bupropion Hcl Sr52%Bupropion Xl48%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

7 NIH research awards on record, funded 1994–2026 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/alan-schatzberg-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Alan-Schatzberg

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • LinkedIn

    linkedin.com/in/alan-schatzberg-a4930915

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Alan-Schatzberg-2126930230

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/p/DJkEgpmNsEZ

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MS (Honoris Causa)

    Harvard University, Medicine

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • Board Certified

    American Board of Psychiatry and Neurology, Psychiatry

    1975
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • MD

    New York University School of Medicine

    1968
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗

Editorial & leadership roles

journal and society appointments
  • President

    American Psychiatric Association

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apaf.org ↗
  • Chair

    Stanford Department of Psychiatry and Behavioral Sciences

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • President

    Society of Biological Psychiatry

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • President

    American College of Neuropsychopharmacology

    2000
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • Co-Editor-in-Chief

    Journal of Psychiatric Research

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Director

    Stanford Mood Disorders Center

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • Co-founder

    Corcept Therapeutics

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Scientific Advisor

    Alto Neuroscience

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altoneuroscience.com ↗
  • Team member/advisor

    Oryzon Genomics (exact role not specified on source page)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oryzon.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.